BiotechFinances

All articles

1 article(s) found

WORLD(United States/Biotech/Proteomics) – Alamar Biosciences completes its IPO on Nasdaq (ticker ALMR), with shares issued at $17 and a first trade at $22.6, valuing the precision proteomics company at roughly $1.5B. Powered by its proprietary NULISA